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ABSTRACT
Utilization of a Metabolic Syndrome Index in Evaluating the Life in BALANCE
Lifestyle Intervention for Prevention of Type 2 Diabetes among
Urban American Indians and Alaska Natives
by
Hongbin Jin
Dr. Michelle Chino, Examination Committee Chair
Associate Professor of Environmental and Occupational Health
School of Community Health Sciences
University of Nevada, Las Vegas
Background: A myriad of diabetes prevention programs modeled on the Diabetes
Prevention Program (DPP) are carried out worldwide to fight against the current diabetes
pandemic. The percentage of weight reduction is a widely used indicator to evaluate
diabetes prevention programs. However, weight change alone may not fully reflect the
efficacy of lifestyle intervention. A metabolic syndrome index is a promising novel scale
for evaluation of diabetes prevention programs because it is a systematic, comprehensive,
and stable indicator that reflects the metabolic risk reduction for diabetes and its
complications at multiple levels and dimensions.
Methods: A total of 22 overweight and obese AI/ANs (age, 39.6 ± 10.4 years; BMI,
34.1± 6.3 kg/m2) at increased risk for developing type 2 diabetes residing in Las Vegas
participated in the LIB program between April, 2010 and December, 2011. Metabolic
syndrome was defined according to the American Heart Association and the National
Heart, Lung, and Blood Institute criteria. Clinical measures were collected at three
different points in time before and after the completion of the LIB lifestyle core
curriculum and the end of post-program follow-up.
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Results: Only 12 of the 22 participants completed the whole LIB program. Among the
five metabolic syndrome components, only waist circumference demonstrated a
significant correlation with weight. After a mean follow-up interval of 10.4 months, the
metabolic syndrome index was reduced by 11% at the completion of the LIB program.
The study population demonstrated significant decreased waist circumference and
elevated HDL cholesterol. Triglycerides manifested the highest percentage change
without statistical significance. No significant change was observed in blood pressure and
fasting blood glucose.
Conclusions: These findings imply that the application of a metabolic syndrome index
provides more detailed information than weight in evaluating diabetes prevention
programs by analyzing pre-post changes in multiple diabetes markers, particularly when
the target population has normal to slightly elevated BMI. Additionally, the changes in
metabolic syndrome components outline the characteristics of diabetes prevention
programs, showing great potential for helping public health professionals to individualize
and optimize program curriculums for different target populations. Promotion of
metabolic syndrome index in diabetes research will establish a unified criterion in
evaluating diabetes prevention programs and facilitate efficacy comparison among
different programs.
Key word: Diabetes; Metabolic syndrome; Prevention; Evaluation
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6

CHAPTER 1
INTRODUCTION

Percentage change from participants’ starting weight is a widely used indicator to
evaluate the efficacy of diabetes prevention programs (Ali, Echouffo-Tcheugui, &
Williamson, 2012). Weight loss is a direct consequence of diet modification and exercise
which are the two most common constructs in diabetes prevention programs. Yet, weight
change alone may not fully reflect the efficacy of lifestyle intervention in terms of
improving prediabetes conditions and reducing the risk of developing type 2 diabetes and
its complications. Additionally, the accuracy and reliability of weight change is
insufficient, since it can be affected by many confounding factors.
Metabolic syndrome, which is associated with central obesity and insulin
resistance, has been demonstrated as a reliable predictor of type 2 diabetes in many
epidemiological studies (Lorenzo, Okoloise, Williams, Stern, & Haffner, 2003; Wilson,
D’Agostino, Parise, Sullivan, & Meigs, 2005; Mannucci et al., 2008; Wassink, Van Der
Graaf, Soedamah-Muthu, Spiering, & Visseren, 2008). The presence of metabolic
syndrome accounts for approximately half of the population attributable risk for diabetes
(Wilson et al., 2005). Previous research studies have shown that, independent of weight
loss, symptoms of metabolic syndrome can be reduced by lifestyle intervention (Christ,
Iannello, Iannello, & Grimm, 2004; Okura et al., 2007; Muzio, Mondazzi, Harris,
Sommariva, & Branchi, 2007; Meckling & Sherfey, 2007; Rector et al., 2007). However,
the extent of improvement in each component of metabolic syndrome varied from project
to project. A metabolic syndrome index is a multivariate parameter incorporating the
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components of metabolic syndrome, which systematically, comprehensively and stably
reflects the metabolic risk for diabetes and its complications.
From the perspective of epidemiology, population attributable risk is employed to
describe risk reduction for a disease or an unhealthy condition objectively. However, a
reduction in incidence cannot be measured without a control group. In this study, we
propose to use a new concept – metabolic risk – in describing and quantifying the risk
reduction caused by diabetes prevention programs. First, type 2 diabetes is a chronic
metabolic disease. Research on metabolic risk factors for type 2 diabetes and its
complications has greatly advanced in past decades and metabolic syndrome has been
widely accepted as a predictor for type 2 diabetes and its complications. Second,
metabolic risk for diabetes and its complications is generally attributable to
environmental and behavioral factors. In other words, this type of risk, to some extent is
separate from genetic risk and can be reduced by lifestyle intervention. The risk reduction
in terms of the improvement in health status can be measured and quantified by a
metabolic syndrome index. Additionally, adoption of metabolic risk is convenient for
public health professionals because it is a direct reflection of the efficacy of diabetes
prevention intervention.
To improve the evaluation methods for diabetes prevention programs to
accurately and objectively reflect the metabolic risk reduction of developing type 2
diabetes and its complications, the metabolic syndrome index should be promoted as a
preferred outcome indicator over weight loss for diabetes prevention programs.
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Purpose of the Study
The purpose of this study is to utilize a novel indicator – the metabolic syndrome
index – to evaluate the Life in BALANCE (LIB) lifestyle intervention for prevention of
type 2 diabetes among urban American Indians and Alaska Natives (AI/AN) residing in
Las Vegas. This study will promote the improvement of evaluation methods for diabetes
prevention programs by creating a new scale to measure the magnitude of metabolic risk
reduction for developing type 2 diabetes and its complications after intensive lifestyle
intervention.

Research Question
Will the metabolic syndrome index be useful in evaluating the Life in BALANCE
lifestyle intervention for prevention of type 2 diabetes among urban AI/ANs residing in
Las Vegas?
Answering this question requires incorporating the following procedures in the
study plan: 1) assess the change of the five components of metabolic syndrome and
weight across the LIB program, 2) analyze the correlation between the five metabolic
syndrome components and weight, and 3) assess the change of the metabolic syndrome
index across the LIB program and compare with weight loss.

Hypotheses
Hypothesis1
H0: There is no significant difference between pre- and post-intervention waist
circumferences among urban AI/ANs residing in Las Vegas.
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HA: There is significant difference between pre- and post-intervention waist
circumferences among urban AI/ANs residing in Las Vegas.
HA1: Post-intervention waist circumference is significantly less than pre-intervention
waist circumference among urban AI/ANs residing in Las Vegas.
Note: This hypothesis will be repeated for systolic blood pressure, diastolic blood
pressure, triglycerides, HDL cholesterol, and fasting blood glucose.
Rationale: Previous research studies have indicated that the five components of
metabolic syndrome respond differently to different lifestyle intervention designs (Christ
et al., 2004; Okura et al., 2007; Muzio et al., 2007; Meckling & Sherfey, 2007; Rector et
al., 2007). To a great extent, the design of a lifestyle intervention curriculum
predetermines its efficacy. Therefore, the first step of this study is to determine whether
the LIB program has reduced the symptoms of metabolic syndrome and the magnitude of
the reductions.
Every program has its strengths and weaknesses, and not every component will
necessarily demonstrate a statistically significant improvement. However, it is good to
know what a program’s strengths so that health professionals can choose the most
effective program. By using a metabolic syndrome index, the magnitude of the change in
the five components can serve as a program’s “resume” by outlining the effect of each
characteristic of a program.
Hypothesis 2
H0: There is no significant correlation between waist circumference and weight among
urban AI/ANs residing in Las Vegas.
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HA: There is significant correlation between waist circumference and weight among
urban AI/ANs residing in Las Vegas.
Note: This hypothesis will be repeated for systolic blood pressure, diastolic blood
pressure, triglycerides, HDL cholesterol, and fasting blood glucose.
Rationale: Theoretically, obesity is connected with the five components of
metabolic syndrome directly or indirectly; however, the strength of their relationships
varies. If a metabolic syndrome component is not correlated with weight, the risk for
diabetes and its complications caused by the component cannot be fully revealed by
weight.
Many research studies have indicated that waist circumference is highly
correlated with body weight, but central obesity characterized by excess accumulation of
abdominal fat is a stronger predictor for diabetes (Feller, Boeing, & Pischon, 2010). If the
remaining four metabolic syndrome components are not significantly correlated with
weight, the risk reduction caused by them cannot be reflected by weight loss alone. This
would support the idea that a metabolic syndrome index is more systematic than weight
loss in evaluating diabetes prevention programs. The hypothetical relationship between
weight and metabolic syndrome is illustrated in Figure 1.
Hypothesis 3
H0: There is no significant difference between pre- and post-intervention metabolic
syndrome indexes among urban AI/ANs residing in Las Vegas.
HA: There is significant difference between pre- and post-intervention metabolic
syndrome indexes among urban AI/ANs residing in Las Vegas.
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HA1: Post-intervention metabolic syndrome index is significantly less than preintervention metabolic syndrome index among urban AI/ANs residing in Las Vegas.
Rationale: The method to calculate the metabolic syndrome index will be
presented in detail in the methods section. This step is to test whether the metabolic
syndrome index has been decreased through the LIB lifestyle intervention. The
magnitude of reduction (percentage change) represents the amount of metabolic risk for
diabetes and its complications that has been reduced.

Figure 1. Hypothetical Relationship between Weight and Metabolic Syndrome in Reflecting the
Real Risk for Diabetes and Its Complications

Significance of the Study
This study will establish a better indicator than weight loss for evaluating diabetes
prevention program outcomes, which systematically, comprehensively and stably
quantifies the risk reduction for diabetes and its complications caused by lifestyle
intervention. Metabolic syndrome reflects more facets of risk for diabetes and its
complications than weight loss and a metabolic syndrome index incorporates this cluster
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of metabolic risk factors and integrates them into one scale. Lastly, by applying the
metabolic syndrome index, a program “resume” will be created to facilitate program-toprogram comparisons, which will greatly enhance the researchers’ ability to select an
intervention program better suited to their study population with increased efficacy.
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CHAPTER 2
REVIEW OF RELATED LITERATURE

Type 2 Diabetes
Diabetes is a global public health crisis affecting all socioeconomic classes and all
races (Caprio et al, 2008). Diabetes is a common, disabling, and deadly disease with an
increasing health and financial burden on individuals and countries. According to the
Center for Disease Control and Prevention (CDC, 2011), in 2010 approximately 8.3% of
the U.S. population (25.8 million) had diabetes and 35% of U.S. adults aged 20 years or
older (79 million) had prediabetes, a condition in which blood glucose levels are higher
than normal but not yet meet the diagnostic criteria for diabetes (ADA, 2012). Diabetes is
the ninth leading cause of death worldwide (WHO, 2008) and the seventh leading cause
of death in the United States (CDC, 2009).
The risk of death in people with diabetes is about twice as that in people without
diabetes (CDC, 2011), which can be largely attributed to the diabetes-related
complications. In addition to the risk of death, long-term complications such as heart
disease, stroke, hypertension, diabetic retinopathy, and amputation drastically increase
medical expenses and severely undermine the life quality of diabetes patients. A recent
estimate reported that the U.S. national economic burden of prediabetes and diabetes
reached $218 billion in 2007 (Dall et al., 2010).
Type 2 diabetes is a chronic disease characterized by increased blood glucose
levels that result from either insufficient insulin production or insulin resistance, a
condition where cells ignore the insulin. It is a multifactorial disease caused by both
genetic factors as well as non-genetic factors that result from individual behavior and
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environment (Report of the Expert Committee on the Diagnosis and Classification of
Diabetes Mellitus, 2003). For example, some specific genes are associated with glucose
homeostasis and regulate the magnitude of the effects of lifestyle choices such as
physical activity (Lakka et al., 2004).
Minorities such as American Indian/Alaska Natives (AI/AN) suffer a
disproportionately high burden of diabetes (Mokdad, Bowman, Enqelqau, & Vinicor,
1998). AI/ANs have the highest age-adjusted prevalence and incidence of diabetes among
all U.S. racial and ethnic groups in spite of the fact that numerous programs funded by
U.S. government have been conducted in AI/AN communities to prevent and treat
diabetes since 1997 (CDC, 2003). The causes of astoundingly high prevalence rates of
diabetes among AI/ANs and other high prevalence populations remain unclear, but the
evident race/ethnicity disparities may be accounted for by genetic predisposition to some
extent. Studies rooted in Neel’s “thrifty genotype” hypothesis advocate that diabetes has
a strong genetic basis (Neel, 1962 & 1999; Ritenbaugh & Goodby, 1989). Previous
genetic research has shown that several genes such as maturity onset diabetes of the
young (MODY) genes and atypical diabetes mellitus (ADM) genes significantly
contribute to some rare forms of diabetes (Benyshek, 2001). However, recent research
suggests that type 2 diabetes has multiple and complex etiologies and genetic factors do
not play a dominant role in this etiological puzzle. Substantial evidence indicated that
maternal glucose during pregnancy is significantly associated with abnormal glucose
intolerance in adulthood. Both nutritional deficits and surplus during prenatal and
perinatal periods lead to increased adipose deposition later in life and raise the risk for
type 2 diabetes (Benyshek, 2007). On the other hand, various behavioral and
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environmental risk factors play important roles in the development of diabetes as well.
Healthy diet and regular physical activity have been linked with a reduced risk of
developing type 2 diabetes in terms of reducing body adiposity, improving insulin
resistance, and ameliorating glucose tolerance (Ross et al., 2000; Kelley & Goodpaster,
2001).
Type 2 diabetes is shaped by a multitude of factors that include genetics,
developmental factors during key stages of early life, lifestyle choices, as well as
socioeconomic barriers. From the perspective of chronic disease epidemiology, a group
of risk factors associated with type 2 diabetes are aging, overweight or obesity, high
blood pressure, high triglyceride level, low HDL cholesterol level, sedentary or inactive
lifestyle, previous positive impaired fasting blood glucose or impaired glucose tolerance,
high-fat diet, family history, ethnicity and race, and gestational diabetes or giving birth to
a low birth weight (< 2.5 kg) or high birth weight (> 4.0 kg) baby (NDEP, 2012).

The Diabetes Prevention Program
Recently, the most inspiring achievement in diabetes research was the Diabetes
Prevention Program (DPP, 2002) funded by the National Institute of Diabetes and
Digestive and Kidney Diseases, which demonstrated that lifestyle changes and metformin
treatment both reduced the incidence of diabetes in high risk population, but the lifestyle
intervention, in particular was more effective in preventing or delaying the development
of diabetes (Knowler et al., 2007).
A myriad of diabetes prevention programs modeled on the DPP are carried out
worldwide to fight against the diabetes pandemic (WHO, 2012). These programs are
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individualized for specific target populations and optimized for the best use of resources
and budgets. Even though most of the programs are translational projects sharing classic
constructs such as lifestyle intervention, diet modification and exercise, the reported
efficacy of these programs differed dramatically due to different program designs and
evaluation methods (Ali et al., 2012).

Weight Loss
Percentage change from participants’ starting weight is a widely used indicator to
assess and evaluate the efficacy of diabetes prevention programs (Ali et al., 2012). The
DPP proclaimed that diabetes can be delayed or averted through systematic and intensive
lifestyle intervention (Knowler et al., 2007). A follow-up study concluded that
intervention to reduce diabetes should primarily target weight reduction (Hamman et al.,
2006). However, even when weight is regained after the DPP, the risk reduction for
diabetes resulting from lifestyle intervention can persist for at least 10 years (Knowler et
al., 2009).
There are many reasons why weight loss is prevailing in diabetes prevention
programs as the main outcome. First, weight loss is an easy and affordable parameter to
be measured repeatedly across the whole program. Second, weight loss is a predictable
consequence of diet modification and exercise which are the two most common
constructs in diabetes prevention programs, and which generally manifests dose-response
relationship. Furthermore, limited by the nature of their study designs and ethical issues,
most diabetes prevention programs are not allowed to include a control group so that they
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fail to measure the “real” risk reduction – the reduced diabetes incidence, which is more
common in long-term cohort or experimental studies.
Overall, weight loss seems to be a rational alternative and has been adopted by
many programs. However, weight loss alone may not fully reflect the efficacy of diabetes
prevention programs in terms of improving prediabetes conditions and reducing the risk
of developing type 2 diabetes and its complications. The Finnish Diabetes Prevention
Study demonstrated that the risk of diabetes was reduced 58% through lifestyle
intervention after a 3-year follow-up in spite of minimal weight loss. More important, the
authors emphasized that exercising 4 hours per week reduced the risk of diabetes in
participants without weight loss (Tuomilehto et al., 2001). Many research studies have
confirmed that beneficial changes in type 2 diabetes incidence can be achieved
independently of weight loss (Pan et al., 1997; Ramachandran et al., 2006). Furthermore,
the accuracy and reliability of weight change is problematic. Loss of muscle and bone
mass instead of fat loss are likely to happen due to unhealthy diet and exercise plans.
Stress caused by dramatic lifestyle change without sufficient family support may also
contribute to weight loss. Additionally, weight measurement can be affected by
confounding factors such as food and fluid intake prior to the measurement.

Metabolic Syndrome
Metabolic syndrome was first recognized by Reaven in 1988 (Reaven, 1988) as a
cluster of risk factors such as dyslipidemia, hypertension, and hyperglycemia for
cardiovascular disease. Later, insulin resistance was introduced into metabolic syndrome
which drastically expanded its application in diabetes research. Findings from the
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Framingham Heart study showed that metabolic syndrome predicted 25% of all new
cases of cardiovascular disease (Grundy, Brewer, Cleeman, Smith, & Lenfant, 2004). The
“common soil” hypothesis suggested that type 2 diabetes and cardiovascular diseases
share pathogenetic pathways (Stern, 1995). It has been widely accepted that metabolic
syndrome is a constellation of metabolic risk factors in a person which contribute to both
atherosclerotic cardiovascular disease and type 2 diabetes (Grundy et al., 2004; Alberti,
Zimmet & Shaw, 2005; Grundy et al., 2005). Several organizations such as the World
Health Organization, the International Diabetes Foundation, and the American Heart
Association have proposed diagnostic criteria for metabolic syndrome in the efforts to
promote its clinical practice in predicting the risk of cardiovascular disease and type 2
diabetes (Alberti & Zimmet, 1998; Balkau & Charles, 1999; Grundy et al., 2004; Alberti
et al., 2005; Grundy et al., 2005). Although there is no consensus criteria for metabolic
syndrome, hyperglycemia, hypertension, obesity, and dyslipidemia have been accepted as
major components for this multiplex risk syndrome. These components connect with each
other and constitute a network to comprehensively measure the risk for diabetes and its
complications. Nonetheless, they are not inter-replaceable due to their independent roles
in human metabolism.
Components of Metabolic Syndrome
Hyperglycemia (fasting blood glucose): Current research suggested that insulin
resistance is the primary cause of metabolic syndrome (Deen, 2004), although the
temporal sequence of insulin resistance and obesity is still unknown. However, insulin
resistance will change the metabolism of carbohydrates and lipids (Shaw et al., 2005).

13

Dyslipidemia (triglycerides and HDL cholesterol): Hyperinsulinemia resulting
from insulin resistance will lead to increased triglycerides and decreased HDL cholesterol
(Shaw et al., 2005), which are common symptoms in type 2 diabetes patients (Moller &
Kaufman, 2005; Alberti et al., 2006).
Hypertension (high systolic blood pressure and/or diastolic blood pressure):
Hypertension has been strongly associated with both glucose intolerance and obesity.
One research study suggested that hypertension is caused by hyperactive sympathetic
nervous systems as a result of hyperglycemia (Shaw, Hall, & Williams, 2005).
Obesity (waist circumference): Obesity has been associated with insulin
resistance, dyslipidemia and hypertension (Grundy et al., 2004) and contributes to the
development of cardiovascular disease. Central obesity, in particular, strongly correlates
with metabolic risk factors (Grundy et al., 2004; Wassink et al., 2008). Waist
circumference is considered as an easy way to determine central obesity (Alberti et al.,
2005).
Despite the fact that different criteria were adopted in epidemiological research,
metabolic syndrome has been recognized as a precursor of cardiovascular disease and
type 2 diabetes (Lorenzo et al., 2003; Wilson et al., 2005). Furthermore, several cohort
studies have indicated that metabolic syndrome is a stronger predictor of type 2 diabetes
than that of cardiovascular disease (Lorenzo et al., 2003; Wilson et al., 2005; Ford, Li, &
Sattar, 2008), which accounts for approximately one fourth and half of the populationattributable risk for cardiovascular disease and diabetes respectively (Wilson et al., 2005).
However, in light of the common pathophysiological pathways, cardiovascular disease
becomes the primary complication of type 2 diabetes. In 2004, heart disease and stroke
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were the top two complications of diabetes which accounted for 84% of deaths related to
diabetes altogether (CDC, 2011).
To calculate the metabolic syndrome index, clinical cutoff values are required in
this process. The criteria of clinical diagnosis of metabolic syndrome proposed by
different organization are summarized in Appendix 1. In this study, the cutoff values
from the American Heart Association (AHA) and the National Heart, Lung, and Blood
Institute (NHLBI) criteria of metabolic syndrome were adopted. The criteria proposed by
the European Group for Study of Insulin Resistance (EGIR) and American Association of
Clinical Endocrinologists (AACE) were excluded from this study because they do not
take patients with diabetes into account, which limits their application in diabetes
prevention programs. The International Diabetes Foundation (IDF) criteria and
AHA/NHLBI criteria are the updated versions for the World Health Organization (WHO)
criteria and the National Cholesterol Education Program’s Adult Treatment Panel III
Report (NCEP) criteria respectively. The advantage of the IDF criteria is that it includes
various waist circumference cutoff values which are specific to different ethnic groups.
However, it doesn’t provide reference values for AI/ANs and many research studies
reported that the criteria of the NCEP are more effective in identifying subjects at risk for
diabetes than the IDF criteria. Updates to the AHA/NHLBI criteria include lowering the
fasting blood glucose threshold to 100 mg/dL, which is consistent with the prediabetes
definition proposed by the American Diabetes Association.
Metabolic syndrome is an effective and efficient indicator in predicting the risk
for developing diabetes and its complications. The question is whether metabolic
syndrome is a sensitive and dynamic parameter in response to the risk reduction caused
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by lifestyle intervention. A secondary analysis of the DPP found that both lifestyle
intervention and metformin therapy reduced the development of the metabolic syndrome
(Orchard, 2005). Further investigations by several studies found that the adoption of
healthy diet and regular exercise, either alone or in combination can improve the
components of the metabolic syndrome in some way (Christ et al., 2004; Okura et al.,
2007; Muzio et al, 2007; Meckling & Sherfey, 2007; Rector et al., 2007). However, the
improvement in the components of metabolic syndrome varied with different levels of
intensity and combinations of interventions.

Rationale for the Metabolic Syndrome Index
The DPP provided a template for future diabetes prevention programs in
establishing basic constructs and timeframes. However, different principles and study
designs have been employed to individualize and optimize these programs. The DPP is a
long-term experimental study (clinical trial) which allows the real risk for diabetes in
terms of the incidence of diabetes to be observed. The highly successful study showed
that a minimum of 7% weight loss or weight maintenance and a minimum of 150 minutes
physical activity per week resulted in a 58% reduction in the incidence rate of diabetes
(DPP, 2002). Unfortunately, most of the translational studies are short-term health
promotion programs, which fail to measure the real risk reduction without controls. Many
translational studies adopt the percentage of weight reduction as a targeted outcome in
order to estimate the real risk reduction through comparison with the DPP. However,
weight loss alone may not be able to reflect the effectiveness of these programs in terms
of ignoring the characteristics in different program designs. For example, the percentage
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of weight loss may be different between a program designed for individuals suffering
from obesity and that of a program designed for individuals suffering from severe insulin
resistance.
Lifestyle intervention for diabetes prevention programs is a multidimensional
process with a series of health promotion strategies at multiple levels. The complexity of
diabetes prevention programs necessitates a comprehensive and integrated indicator to
evaluate their efficacy. Unlike the weight loss, the components of metabolic syndrome
provide a multivariate parameter which covers more aspects of risk reduction caused by
lifestyle intervention. A metabolic syndrome index is a systematic and comprehensive
indicator that can be used to evaluate the efficacy of diabetes prevention programs
because it measures risk reduction for diabetes and its complications at multiple levels
and dimensions. A reduction in the metabolic syndrome index reflects the risk reduction
for diabetes and its complications resulting from a diabetes prevention program, which
makes program-to-program comparison possible. In addition, the five components of the
metabolic syndrome index, to some extent represent different aspects of the risk for
diabetes and its complications. The magnitude of change in the five components outlines
the strengths and weaknesses of a program, which can serve as a useful reference for
researchers to choose the best program for specific populations.
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CHAPTER 3
METHODS

Calculation Method for the Metabolic Syndrome Index
A metabolic syndrome index is a five-point scale that assigns one point to each of
the five metabolic syndrome components - waist circumference, blood pressure,
triglycerides, high-density lipoprotein (HDL) cholesterol, and fasting blood glucose. The
clinical cutoff values for this study were those from the metabolic syndrome criteria
proposed by the American Heart Association (AHA) and the National Heart, Lung, and
Blood Institute (NHLBI) in 2005 (Grundy et al., 2005).
The five components are assumed to be equally important for diabetes and its
complications because each component is assigned one point only. The component
equality is assured by the AHA/NHLBI definition, which is defined as the presence of
any three or more of the following five components - central obesity (waist
circumference > 102 cm for men, > 88 cm for women), elevated triglycerides (≥ 150
mg/dL), hypertension (systolic BP ≥ 130 mmHg, and/or diastolic BP ≥ 85 mmHg), raised
fasting blood glucose (≥ 100 mg/dL), and reduced HDL cholesterol (< 40 mg/dL for men,
< 50 mg/dL for women). By adjusting the clinical cutoff values, a balance is reached
among the five components, guaranteeing that they contribute equally to a metabolic
syndrome diagnosis.
One point will be counted if a component meets the clinical criteria above and a
total score will be calculated as the metabolic syndrome index for each participant. A
range from zero to five quantifies the metabolic risk for diabetes and its complications
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which can be reduced by lifestyle intervention. A metabolic syndrome index should be
measured at least twice (before and after intervention) in order to calculate the magnitude
of the risk reduction potentially resulting from the intervention.

Data Collection and Treatment
The Life in BALANCE (LIB) project, conducted by the University of Nevada,
Las Vegas, was a community-based participatory research project to pilot a translational
study that modeled the Diabetes Prevention Program (DPP) intensive lifestyle coaching
intervention in urban American Indian/Alaska Native (AI/AN) population. AI/ANs suffer
a disproportionately high burden of type 2 diabetes and the incidence has been escalating
at an alarming rate since the early 1960s (Valway et al., 1993). Urban AI/AN populations,
which account for 60% of AI/ANs, may confront a worse scenario because they are
affected more by modernized lifestyles and benefit less from the health services provided
by tribal reservations and the Indian Health Service (IHS). The LIB program provided an
opportunity to study the full extent of the problem of diabetes in this underserved
population and utilize a metabolic syndrome index in evaluating the LIB pilot study in
urban AI/AN population.
The LIB project was a pre-experimental study (one group pre-test and post-test
study). Non-clinical and clinical data were obtained from the LIB intensive lifestyle
intervention pilot study. A secondary analysis was performed to answer the research
question and hypotheses.
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The LIB project was approved by the University of Nevada Las Vegas
Institutional Review Board. All research activities were designed to have minimal risk to
participants. Informed consent was required for all participants.
Target Population
The pilot study targeted urban AI/AN residents in Las Vegas, Nevada at increased
risk for developing type 2 diabetes. Participants were recruited through community
screenings, media announcements and referrals from other participants and/or project
members. Six free community screenings were held at the Las Vegas Indian Center and
Southern Nevada Native American Educational Coalition event in order to recruit
qualified participants. The criteria for “increased risk” were defined as being overweight
or obese and a glycosylated hemoglobin (HbA1c) level between 5.4% and 6.4% via a
finger stick blood draw. Participants who met the inclusion criteria were informed about
the LIB study and those who agreed to participate in would receive a 16-week core
curriculum and regular follow-up.
Inclusion Criteria
1. Age 21 and older
2. Self-identified AI/AN ethnicity
3. Body mass index (BMI) ≥ 25 kg/m2
4. HbA1c between 5.4% and 6.4%
The LIB program was optimized and individualized for adult AI/ANs at high risk
for type 2 diabetes. The presence of a BMI of 25 kg/m2 and above (overweight) and a
glycosylated hemoglobin level between 5.4% and 6.4% diagnosis were essential risk
factors identifying high-risk potential participants for the study.
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Exclusion Criteria
1. Major illness, myocardial infarction, symptoms of coronary heart disease, previous
diabetes diagnosis, and pregnancy
2. Use of medication improving glucose tolerance (e.g., metformin)
3. Use of medication impairing glucose tolerance
The LIB program involved intensive lifestyle intervention which might be
harmful for individuals with major illness or compromised health conditions. Individuals
with previous diabetes diagnosis were excluded because the LIB program was designed
to prevent the development of diabetes. Individuals using medications interfering glucose
tolerance were excluded to avoid introducing a major confounding factor in this study.
Non-Clinical and Clinical Measures
Non-clinical data were obtained before and after the completion of the LIB
lifestyle core curriculum. A baseline survey and a post-participation survey were
conducted by lifestyle coaches.
Clinical measures were collected at three different points in time before and after
the completion of the LIB lifestyle core curriculum and the end of post-program followup. All clinical procedures were followed standardized protocols and performed by
trained clinical specialists. Clinical measures of interest included weight, waist
circumference, blood pressure, triglycerides, HDL cholesterol, and fasting blood glucose.
Data Security
All survey data were secured with locked file cabinets and password protected
computers at the American Indian Research and Education Center at University of
Nevada Las Vegas. Biological samples were immediately analyzed and promptly
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disposed afterward. All clinical data were stored in a secure digital database with
restricted access. Each participant was assigned a unique identification number which
disconnects the link between research data and participants’ identifiable information. All
participants’ identifiable information was accessible to senior research team members
only. Each member of the research team was required to complete the Collaborative
Institutional Training Initiative (CITI) Human Subjects Protections training prior to
conducting research activities with the LIB program. The principal investigator was
responsible for supervising all data collection activities.
Data Management
All question choices and responses were numbered by different coding formats
for further statistical analysis. Non-clinical and clinical data were compiled into
Microsoft Excel spreadsheets. A data codebook was developed to code and decode data.
Data cleaning, recoding, and statistical analysis were performed after the completion of
data collection.

Statistical Methods
This study was a pilot study with a small sample size (n=22). Considering the
magnitude of attrition rates (31.8% and 45.5% at the completion of the core curriculum
and follow-up respectively), two separate group analyses were conducted for each test.
The first one was to analyze only the participants who completed the entire LIB program.
The second one was to analyze all the participants including those who dropped out
before completing the program by employing a simple intention-to treat analysis (last
observation carry-forward analysis). The purpose of the intention-to-treat analysis is to
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avoid the effects of a high drop-out rate because it is reported that participants who
completed a program are more likely to show expected change than those who dropped
out, hence skewing the results towards positive outcomes. The results from the two
analyses were reported independently and a comparison was done to reveal whether the
positive change was a potential result from intervention. Variables of interest are
summarized in Table 1.

Table 1. Variables of Interest
Variables

Type

Range

Values / Clinical Cut-off Values

Sex

Categorical

0/1

0 = Male
1 = Female

Age (years)

Continuous

Education (%)

Categorical

0/1

0 = Without bachelor degree
1 = Bachelor degree or higher

Employment (%)

Categorical

0/1

Household income (%)

Categorical

0/1

Weight (kg)

Continuous

Waist circumference (cm)

Continuous

102 in men, 88 in women

Systolic blood pressure (mmHg)

Continuous

130

Diastolic blood pressure (mmHg)

Continuous

85

Triglycerides (mg/dL)

Continuous

150

HDL cholesterol (mg/dL)

Continuous

40 in men, 50 in women

Fasting blood glucose (mg/dL)

Continuous

100

Metabolic syndrome index

Categorical

0 = Unemployed
1 = Employed
0 = Less than $ 50,000 per year
1 = 50,000 or greater per year

0-5

The SPSS statistical package (SPSS 19, IBM, Armonk, NY) was used for data
analysis. All statistical tests were two-tailed. The overall statistical significance level was
set to α = 0.05.

23

Descriptive statistics was used to summarize the data. Mean, median and standard
deviation were used to describe the central tendency and the dispersion for the variables
of interest.
Both the histogram and Kolmogorov-Smirnov test indicated that the pilot data
violated the normal distribution assumption, which cannot be corrected by data
transformation. Therefore, nonparametric methods were employed in the data analysis.
The Wilcoxon signed-rank test and the Fisher’s exact test were used to compare
the differences of demographic information and baseline clinical measures between
participants who completed the program and those who dropped out.
Hypothesis 1 and 3: The Friedman test was used to analyze the change of the
variables of interest across the three time points. Post hoc analysis with Wilcoxon signedrank tests was conducted with a Bonferroni correction applied, resulting in a significance
level set at p < 0.0167. Intention-to-treat analysis was applied in this step.
Hypothesis 2: The Spearman's rank correlation coefficient was used to analyze the
correlation between the components of metabolic syndrome and weight. Intention-to-treat
analysis was applied in this step.
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CHAPTER 4
RESULTS

A total of 22 (age, 39.6 ± 10.4 years; BMI, 34.1± 6.3 kg/m2) subjects were
enrolled in this pilot study, 17 (77.3%) of them were female. Ten participants dropped
out of the program before completion (dropout rate: 45.5%). The demographic
information and baseline clinical data are summarized in Table 2. Based on subjects’
characteristics at entry there were no significant differences in demographic information
and clinical measures between those participants who completed the program and those
who dropped out of the program.

Table 2. Demographic Characteristics and Baseline Clinical Measures of the Study Population
Variables

Participants who completed
the program (n=12)

Participants who dropped
out (n=10)

p-value

Female (%)

83.33

70.00

0.624

Age (years)

38.58 ± 9.55

40.70 ± 11.81

0.923

Education (%)

0.074

Without bachelor degree

50.00

90.00

Bachelor degree or higher

50.00

10.00

Employment (%)

0.293

Unemployed

8.33

30.00

Employed

91.67

70.00

Household income (%)

1.000

< $ 50,000

66.70

70.00

≥ $ 50,000

33.30

30.00

Weight (kg)

96.67 ± 12.50

94.63 ± 28.64

0.381

Waist circumference (cm)

110.89 ± 11.40

113.00 ± 21.64

0.974

Triglycerides (mg/dL)

189.92 ± 109.41

152.10 ± 47.10

0.539
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HDL cholesterol (mg/dL)

49.91 ± 15.42

48.00 ± 7.17

0.863

Fasting blood glucose (mg/dL)

107.17 ± 10.26

107.50 ± 6.40

0.923

Systolic BP (mmHg)

121.03 ± 14.49

116.99 ± 11.81

0.628

Diastolic BP (mmHg)

78.07 ± 11.08

74.70 ± 8.04

0.418

a.
b.

Values shown are mean values ± standard deviation (SD).
Results are based on the Wilcoxon signed-rank test and the Fisher’s exact test.

After the LIB intensive lifestyle intervention, 12 completers demonstrated a
statistically significant drop in weight (5.79%, p=0.01) with a range of -2.82% to 14.23%,
in spite of the fact that two-thirds of them did not achieve the goal of a 7% weight loss.
Metabolic syndrome symptoms were improved to different extents at completion. Of the
five components, only waist circumference and HDL cholesterol demonstrated
statistically significant improvements (5.79%, p=0.01 and 12.92% p=0.007). Waist
circumference decreased steadily across the three time points, but HDL cholesterol did
not start to rise until completing the core curriculum. Triglycerides had the largest
reduction (15.89%), but the change was not statistically significant and with high
variability. Systolic blood pressure decreased more than diastolic blood pressure. Fasting
blood glucose showed very limited improvement after the program (Table 3.1 & 3.2).

Table 3.1. Comparison of Three Clinical Measures (n=12)
Variables

Baseline (1st)

Completed core
curriculum (2nd)

Follow up (3rd)

p-value

Change

Weight (kg)

96.67± 12.50

93.53 ± 12.44

91.07 ± 10.37

0.010*

- 5.79%

Waist circumference (cm)

110.89 ± 11.40

108.20 ± 11.66

106.08 ± 11.09

0.010*

- 4.34%

Triglycerides (mg/dL)

189.92 ± 109.41

158.42 ± 75.30

159.75 ± 72.14

0.717

- 15.89%

HDL cholesterol (mg/dL)

49.91 ± 15.42

48.64 ± 15.00

56.36 ± 14.62

0.007*

+ 12.92%

Fasting glucose (mg/dL)

107.17 ± 10.26

105.17 ± 7.94

106.75 ± 4.90

0.502

- 0.39%

Systolic BP (mmHg)

121.03 ± 14.49

117.00 ± 10.26

113.72 ± 10.25

0.338

- 6.04%

Diastolic BP (mmHg)

78.07 ± 11.08

78.71 ± 12.02

76.55 ± 11.82

0.779

- 1.95%
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Table 3.2. Post Hoc Tests
Variables

1st vs. 2nd

1st vs. 3rd

2nd vs. 3rd

Weight (kg)

1st > 2nd, p = 0.003

1st > 3rd, p = 0.012

2nd = 3rd, p = 0.347

Waist circumference (cm)

1st > 2nd, p = 0.016

1st = 3rd, p = 0.050

2nd = 3rd, p = 0.230

HDL cholesterol (mg/dL)

1st = 2nd, p = 0.212

1st = 3rd, p = 0.045

2nd < 3rd, p = 0.004

a.
b.
c.
d.
e.
f.

1st refers to the first clinical measure before the LIB program; 2nd refers to the second clinical measure at
the completion of the LIB core curriculum; 3rd refers to the third clinical measure at the end of follow-up.
This procedure only included participants completing all three clinical measurements (n=12).
Values shown are mean values ± standard deviation (SD).
Results are based on the Friedman test.
Post hoc results are based on the Wilcoxon signed-rank test with a Bonferroni correction (p < 0.0167);
insignificant results are reported as equality, and no post hoc analysis was done.
* indicates significant at 0.05.

The results from the intention-to-treat analysis were highly consistent with those
from the original analysis (Table 4.1 & 4.2), indicating that positive findings did not
result from removing the data of drop-outs. However, the results from the intention-totreat analysis are not considered in the final results due to the risk of introducing bias and
inflating type I error.

Table 4.1. Comparison of Three Clinical Measures with Intention-to-treat Analysis (n=22)
Variables

Baseline (1st)

Completed core
curriculum (2nd)

Follow up (3rd)

p-value

Change

Weight (kg)

95.74 ± 20.84

93.87 ± 20.90

92.53 ± 20.36

0.008*

- 3.35%

Waist circumference (cm)

111.85 ± 16.43

109.95 ±16.96

108.79 ± 16.92

0.001*

- 2.74%

Triglycerides (mg/dL)

172.73 ± 87.14

151.18 ± 61.34

151.91 ± 59.41

0.581

- 12.05%

HDL cholesterol (mg/dL)

49.00 ± 11.67

48.91 ± 11.58

52.91 ± 11.89

0.002*

+ 7.98%

Fasting glucose (mg/dL)

107.32 ± 8.53

105.86 ± 6.98

106.73 ± 5.26

0.382

- 0.55%

Systolic BP (mmHg)

119.19 ± 13.19

115.46 ± 11.64

113.67 ± 11.51

0.245

- 4.63%

Diastolic BP (mmHg)

76.54 ± 9.74

75.71 ± 10.76

74.53 ± 10.35

0.368

- 2.63%
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Table 4.2. Post Hoc Tests with Intention-to-treat Analysis (n=22)
Variables

1st vs. 2nd

1st vs. 3rd

2nd vs. 3rd

Weight (kg)

1st > 2nd, p = 0.005

1st > 3rd, p = 0.013

2nd = 3rd, p = 0.347

Waist circumference (cm)

1st > 2nd, p = 0.004

1st > 3rd, p = 0.013

2nd = 3rd, p = 0.230

HDL cholesterol (mg/dL)

1st = 2nd, p = 0.723

1st < 3rd, p = 0.010

2nd < 3rd, p = 0.004

a.
b.
c.
d.
e.
f.

1st refers to the first clinical measure before the LIB program; 2nd refers to the second clinical measure at
the completion of the LIB core curriculum; 3rd refers to the third clinical measure at the end of follow-up.
This procedure included all the participants (n=22).
Values shown are mean values ± standard deviation (SD).
Results are based on the Friedman test.
Post hoc results are based on the Wilcoxon signed-rank test with a Bonferroni correction (p < 0.0167);
insignificant results are reported as equality, and no post hoc analysis was done.
* indicates significant at 0.05.

In the correlation analysis, a significant correlation between waist circumference
and weight was detected, which is in line with the anticipated result. No other metabolic
syndrome components were correlated to weight (Table 5).

Table 5. Correlation between Weight and Metabolic Syndrome Components (n=22)
Waist
circumference

Triglycerides

HDL
cholesterol

Fasting
glucose

Systolic BP

Diastolic BP

Rho

0.733*

- 0.032

- 0.188

0.276

0.214

0.204

p-value

<0.001

0.825

0.201

0.055

0.139

0.160

Weight

a.
b.
c.

This procedure included all the participants (n=22) with censored data.
Results are based on the Spearman’s rank correlation coefficient.
* indicates significant at 0.05.

The metabolic syndrome index had an 11% drop in total score for the participants
completing the LIB program, which was not statistically significant. The decrease was
not evident until the completion of the core curriculum (Table 6).
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Table 6. Comparison of Three Metabolic Syndrome Index Measures (n=12)
Variables

Baseline (1st)

Completed core
curriculum (2nd)

Follow up (3rd)

p-value

Change

Metabolic Syndrome Index

3.00 ± 1.41

3.00 ± 1.35

2.67 ± 0.99

0.256

- 11.00%

a.

1st refers to the first clinical measure before the LIB program; 2nd refers to the second clinical measure at
the completion of the LIB core curriculum; 3rd refers to the third clinical measure at the end of follow-up.
b. This procedure only included participants completing all three clinical measurements (n=12).
c. Values shown are mean values ± standard deviation (SD).
d. Results are based on the Friedman test.
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CHAPTER 5
DISCUSSION, LIMITATIONS, AND CONCLUSIONS

Discussion
A weight loss of 7% of initial body weight was set as the primary study goal for
the LIB program, because it is deemed to be safe, effective, and feasible for participants
to maintain over a long-term follow-up. Unfortunately, weight loss data failed to
demonstrate the efficacy of the LIB program in minimizing the risk for diabetes because
the 12 participants completing the program had an average weight loss of 5.79% at
completion. Weight loss alone, however, cannot quantify the magnitude of risk reduction
for diabetes and its complications. A metabolic syndrome index introduced a novel
approach and an informative framework from which to evaluate LIB program outcomes.
In the present study a significant correlation was found between weight and waist
circumference across the program spectrum. Weight and waist circumference are
universal parameters in estimating general and abdominal obesity respectively. Abnormal
body fat distribution, particularly around abdomen, is highly associated with an increased
risk for diabetes, even if the BMI falls within the normal range (Schulze et al., 2006). A
German research team pointed out that waist circumference gives a better prediction of
diabetes risk than BMI because development of diabetes is influenced more by visceral
fat tissue which is metabolically more active and produces more hormones and cytokines,
and this relationship is more pronounced in people with normal BMI (Feller, Boeing, &
Pischon, 2010). Statistically speaking, weight might be an inferior alternative to waist
circumference (r = 0.733, p < 0.001), but it cannot take over the roles of other metabolic
risk factors, which was evidenced by the non-significant correlation between weight and
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triglycerides, HDL cholesterol, fasting glucose and blood pressure seen in the present
study. Obesity plays a role in hyperinsulinemia, insulin resistance, dyslipidemia, and
hypertension. However, the pathogenetic interactions do not allow obesity to serve a
substitute for the other metabolic syndrome components. This inference is supported by
the high prevalence of metabolic syndrome among individuals with normal to slightly
elevated BMI (St-Onge, Janssen, & Heymsfield, 2004) and significant type 2 diabetes
incidence reduction after lifestyle intervention with minimal weight loss (Tuomilehto et
al., 2001).
The metabolic risk for diabetes and its complications has a multifaceted structure
comprising environmental and behavioral factors. Lifestyle intervention for diabetes
prevention programs works on these facets simultaneously with complex health
promotion strategies. A metabolic syndrome index acts as a systematic and
comprehensive indicator in evaluating the efficacy of lifestyle interventions by targeting
the five principal metabolic factors. The results of the current study indicated that the LIB
lifestyle intervention succeeded in lowering the metabolic risk for diabetes and its
complications by 11% among the small pilot population. Since metabolic risk is an
estimate of a modifiable proportion of the risk for diabetes and its complications, this
parameter is more pragmatic for public health professionals by separating from nonmodifiable risk like genetic predisposition or developmental metabolic programming.
The value was higher than the percentage of weight loss, suggesting that a metabolic
syndrome index covered more aspects of the risk for diabetes and its complications which
cannot be revealed by weight alone.
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The metabolic syndrome components responded differently to the LIB lifestyle
intervention. Only waist circumference and HDL cholesterol demonstrated statistically
significant improvement. Waist circumference manifested a significant correlation with
weight. Both of them showed a significant reduction at the completion of the core
curriculum, although this trend slowed down in the follow-up period. The core
curriculum was the most structured phase of the LIB lifestyle intervention involving
increased physical activity and decreased calorie and fat intake. All the participants were
required to set individualized goals for weight loss and fat/calorie intake before the core
curriculum and were encouraged to achieve these goals within 4 months. The early
achievement of a significant reduction of waist circumference might be attributed to the
presence of lifestyle coaches and an incentive package that included a free gym
membership. With the guidance and supervision of the lifestyle coaches as well as
accessible sports apparatus, participants were more prone to follow the scheduled
exercise and diet plan. However, after removing extrinsic motivations, a self-managed
and self-monitored plan was employed to reinforce the acquired positive behavioral
changes in the follow-up period, which might have contributed to the deceleration of the
waist circumference reduction. No weight and waist circumference regain occurred at the
end of the follow-up period, indicating that the core curriculum was effective in helping
participants master weight maintenance skills and the effect of the LIB lifestyle
intervention persisted at least 35 weeks. Considering the efficiency of weight loss and
waist circumference reduction seen during the core curriculum, an extension of the core
curriculum may be helpful to achieve the original goal of a 7% weight loss.
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HDL and triglycerides are two typical lipoproteins in diabetic dyslipidemia,
although their responses to lifestyle interventions may differ. A 36-month clinical trial in
Germany found that both diet alone and diet combined with exercise decreased
triglyceride levels and increased HDL cholesterol values in participants with metabolic
syndrome (Christ et al., 2004). Two similar studies in Italy and the United States found
that no change occurred in HDL cholesterol from baseline after 5-month and 6-month
lifestyle intervention respectively, regardless of a significant reduction in waist
circumference and triglyceride levels (Muzio et al., 2007 & Rector et al., 2007). Results
from the three studies suggest that triglycerides have a quick response to lifestyle
intervention while HDL cholesterol demands a longer period to manifest observable
positive change. In the present study, HDL cholesterol remained steady throughout the
16-week core curriculum, but a statistically significant elevation was observed during the
follow-up period. No significant change was detected in triglycerides, but these showed
the highest percentage of decrease which mainly occurred during the core curriculum.
These findings are in concordance with the assumption above, indicating that elevation of
HDL cholesterol has a long lag time and a 16-week ongoing LIB lifestyle intervention is
effective to increase HDL cholesterol in the long term.
Many studies have indicated that hypertension can be relieved through lifestyle
intervention, especially in decreasing systolic blood pressure (Christ et al., 2004,
Meckling et al., 2007). A smaller decrease was observed in diastolic blood pressure
compared with systolic blood pressure in the present study, but neither was statistically
significant. One possible explanation is that the average baseline blood pressure among
our participants was within normal range (systolic BP: 119.19 ± 13.19 mmHg; diastolic
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BP: 76.54 ± 9.74 mmHg), which might have limited the effect of the LIB lifestyle
intervention in alleviating hypertension.
Hyperglycemia is one of the primary symptoms in individuals with prediabetes
and diabetes. It is also the most intractable target in diabetes prevention programs. Diet
and exercise are widely perceived to be beneficial for glycemic control. However,
conflicting results on the effects of lifestyle intervention in improving hyperglycemia are
common in clinical trials. In the present study, fasting blood glucose was not affected by
the LIB lifestyle intervention. In addition, no sign of improvement in long-term glycemic
control was observed, which was evidenced by stable glycosylated hemoglobin (HbA1c)
levels (data not shown). This finding is consistent with a recent study in an overweight
and obese female Canadian population, reporting that fasting blood glucose was not
affected by diet and exercise regardless of a significant weight loss (Meckling et al.,
2007). Moderate weight loss is beneficial in improving insulin resistance (Reaven, 2005).
Previous studies have shown that a 10% weight loss lowers blood glucose and improves
cardiovascular risk factors. It is possible that an average weight loss of less than 10% is
not sufficient to trigger a detectable reduction of blood glucose. On the other hand,
considerable evidence showed that isocaloric diet, low in fat and enriched in
carbohydrates, will exacerbate insulin resistance. Replacing saturated fat with
carbohydrates may increase daily blood glucose level because it requires more insulin to
maintain glucose homoeostasis, which is demanding in individuals with insulin resistance
(Reaven, 2005). The LIB core curriculum emphasizes reducing fat and total calorie intake
without a structured guide for dietary macronutrient content. High levels of carbohydrate
intake might have counteracted the effect of weight loss in improving insulin resistance
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and lowering blood glucose. The addition of a structured dietary macronutrient content
guide in the LIB core curriculum may be effective in achieving more weight loss and an
observable fasting blood glucose reduction.
In summary, the results indicate that the LIB program reduced the metabolic risk
for diabetes and its complications by 11% in urban Native Americans living in Las Vegas
with increased diabetes risk. The current LIB core curriculum is effective in decreasing
waist circumference and elevating HDL cholesterol level. Further research is needed to
investigate the effect of an extended and optimized core curriculum in strengthening the
efficacy of the LIB program.

Limitations
Some limitations of this study have to be taken into account. First, this pilot study
has a small sample size. Even the intention-to-treat analysis indicates that the positive
changes may be attributable to the lifestyle intervention itself, but large variability
resulting from a small sample size may mask some significant results. Second, the last
follow-up visit was completed at either 8 months or 12 months after the first clinical
measure, resulting in a follow-up period varied from 8.1 months to 12.8 months.
Theoretically acquired positive behaviors gradually weaken over time without proper
reinforcement. Participants who had an early follow-up visit might behave better than
those who had a late follow-up visit, which might have influenced the last clinical
measure. Third, due to the nature of secondary analysis, some important confounding
factors cannot be included in this study. Social support is crucial in shaping and
consolidating individuals’ positive behaviors. Information like marital status was not
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collected in the LIB pilot study, which might also contribute to a high dropout rate.
Information on lifestyle choices like smoking and drinking was not collected as well,
which play a role in increasing metabolic risk related to diabetes, which might have
attenuated the effects of the LIB program.

Conclusions
In conclusion, findings from the present study imply that the application of the
metabolic syndrome index provides more detailed information in addition to weight in
evaluating diabetes prevention program outcomes by analyzing pre-post changes in
multiple diabetes markers, particularly when the target population has normal to slight
elevated BMI. It also serves as comparison for other evaluation tools used in diabetes
prevention programs by reporting the amount of metabolic risk for diabetes and its
complications that has been reduced. Additionally, the changes in metabolic syndrome
components outline the characteristics of diabetes prevention programs, showing great
potential for helping public health professionals to individualize and optimize program
curriculums for different target populations. Promotion of metabolic syndrome index in
diabetes research will establish a unified criterion in evaluating diabetes prevention
programs and facilitate efficacy comparison among different programs.
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APPENDIX 1
SUMMARY OF METABOLIC SYNDROME CRITERIA
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